These findings demonstrate the need for active IL-6 signaling during MAP infection to preserve intestinal epithelial integrity and health during infection and would shift therapeutic strategies to mechanisms that finetune IL-6 levels instead of eliminating it. This evidence concerns the gene IL6 and infection.